Parkinson's disease in Gaucher disease patients: what's changing in the counseling and management of patients and their relatives?

Orphanet J Rare Dis. 2020 Sep 23;15(1):262. doi: 10.1186/s13023-020-01529-y.

Abstract

Background: How to address the counseling of lifetime risk of developing Parkinson's disease in patients with Gaucher disease and their family members carrying a single variant of the GBA1 gene is not yet clearly defined. In addition, there is no set way of managing Gaucher disease patients, taking into account the possibility that they may show features of Parkinson's disease.

Methods: Starting from an overview on what has recently changed in our knowledge on this issue and grouping the experiences of healthcare providers of Gaucher disease patients, we outline a path of counseling and management of Parkinson's disease risk in Gaucher disease patients and their relatives.

Conclusion: The approach proposed here will help healthcare providers to communicate Parkinson's disease risk to their patients and will reduce the possibility of patients receiving inaccurate information from inadequate sources. Furthermore, this resource will help to empower healthcare providers to identify early signs and/or symptoms of Parkinson's disease and decide when to refer these patients to the neurologist for appropriate specific therapy and follow-up.

Keywords: Counseling; Gaucher disease; Management; Risk of Parkinson’s disease.

MeSH terms

  • Adult
  • Child
  • Counseling*
  • Family Health
  • Gaucher Disease* / complications
  • Gaucher Disease* / genetics
  • Glucosylceramidase / genetics
  • Humans
  • Parkinson Disease* / complications
  • Quality of Life

Substances

  • Glucosylceramidase